Enjoy complimentary customisation on priority with our Enterprise License!
The global breast biopsy devices market size is estimated to grow by USD 721.64 million between 2022 and 2027 accelerating at a CAGR of 10.95%.
This breast biopsy devices market report extensively covers market segmentation by Product (biopsy needles and systems, biopsy image-guided systems, and others), End-user (hospitals, ascs, breast cancer specialty centers and clinics, and others), and Geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges.
Cancer is a significant public health concern worldwide and a leading cause of death. Breast cancer is a common form of cancer, primarily found in women, especially those aged 65 and above. Younger women are also at risk, particularly those with a genetic predisposition or mutations in their BRCA1 and BRCA2 genes. Breast cancer screening through mammograms, ultrasounds, and MRI helps in early detection and diagnosis, leading to proper treatment. The rising incidence of breast cancer globally is driving the demand for breast biopsy procedures, boosting the growth of the global breast biopsy devices market.
View the Bestselling Market Research Sample
Lockdowns were imposed in North America in 2020 due to the COVID-19 pandemic, leading to a decline in the demand for medical devices, including breast biopsy devices. However, with the lifting of restrictions in the second half of 2020, operations resumed in clinics and hospitals, and the demand for breast biopsy devices is expected to increase during the forecast period due to the growing number of breast cancer cases in the region. As of January 2022, more than 3.8 million women in the US have a history of breast cancer, with breast cancer being the most common malignancy among American women. These factors are anticipated to drive the demand for breast biopsy, leading to the growth of the breast biopsy devices market in North America.
Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Breast biopsy devices are diverse and the top vendors aim to enhance their product offerings by obtaining regulatory approvals and showcasing their products at conferences to raise awareness about breast cancer screening. This approach helps attract end-users and expand their product portfolios.
Some of the products in the market that have received regulatory approval and have been showcased by vendors include the following:
The demand for advanced breast biopsy devices has increased due to the rising adoption of minimally invasive procedures for breast cancer screening. Robotic platforms, surgical navigation systems, and artificial intelligence are in high demand due to their accuracy and efficiency. The use of robotics in MRI systems can localize breast abnormalities and improve procedural efficacy. Vendors are also developing AI-integrated solutions to help doctors analyze breast cancer and reduce human errors. For instance, Hunt Regional Healthcare's ProFound AI tool can detect malignant tissue and calcifications, reducing errors and saving time during breast biopsies.
Physicians prefer core needle biopsy, FNA biopsy, and surgical biopsy to detect and identify breast cancer. The biopsy method used depends on the patient's situation, and guidance systems help in performing these procedures. Breast biopsy procedures have risks and complications. Liquid biopsy, a non-invasive process that analyzes a blood sample, is an alternative to core needle biopsy and surgical breast biopsy. It allows healthcare providers to obtain comprehensive information about the tumor and monitor disease progression without surgery. Liquid biopsy's easy acceptance, non-invasiveness, and quick results drive its adoption. The availability of alternative methods is a challenge to the adoption of traditional breast biopsy techniques and devices. Advances in liquid breast biopsy techniques are expected to increase their adoption during the forecast period.
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
BIOPSYBELL Srl - The company offers breast biopsy devices and related products such as Moon Needle for the localization of breast lesions. The company manufactures medical equipment for surgeries such as assisted reproductive technology, ortho biologics, spine, and others.
The report also includes detailed analyses of the competitive landscape of the market and information about prominent and key market vendors, including:
Technavio’s report consists of a holistic analysis of the key development analysis, development stage, key market players, their marketing strategies, and powerful innovations to help any client gain a competitive edge.
The market share growth of the biopsy needles and systems segment will be significant during the forecast period. Breast biopsy needles are primarily used for collecting breast tissue from the suspicious areas of the breast during a breast biopsy. Needle biopsy is considered the gold standard procedure for breast biopsies. Core needle biopsy is a quick process for breast biopsy, which does not involve surgery. Owing to these factors, breast biopsy needles are accepted by physicians for standard breast biopsy procedures.
Get a detailed analysis of various segments View Sample PDF
Hospitals are the key end-users of the global breast biopsy devices market, and they majorly influence market growth. Large and medium-sized hospitals are focusing on improving their services by offering extensive oncology services, for which they are purchasing or procuring advanced breast biopsy devices. Most of the small hospitals have budget constraints. Hence, to reduce their expenses, such end-users avoid purchasing high-end breast biopsy devices, such as breast biopsy image-guided systems like MRI systems. To improve patient care and to offer better results, hospitals are offering interventional oncology services. Therefore, the growing number of breast cancer cases, the availability of breast cancer screening programs, and the increasing adoption of breast biopsy devices to improve surgical efficacy will boost the market growth during the forecast period.
For more insights on the market share of various regions View PDF Sample now!
North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The prevalence of cancer has increased in North America. Cancer is the most common disease found in the population in this region. The region has been witnessing an increase in the adoption of various advanced technologies over the past few years. The majority of the market growth in this region is driven by high technology adoption in the healthcare sector, increasing healthcare expenditure, rising prevalence of breast cancer, and growing awareness among patients about mammograms to identify breast cancer incidence.
Breast Biopsy Devices Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2022 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 10.95% |
Market growth 2023-2027 |
USD 721.64 million |
Market structure |
Fragmented |
YoY growth (%) |
8.93 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 39% |
Key consumer countries |
US, Canada, Germany, France, and China |
Competitive landscape |
Leading companies, Competitive Strategies, Consumer engagement scope |
Key companies profiled |
Advin Health Care, Allengers Medical Systems Ltd., Argon Medical Devices Inc., Becton Dickinson and Co., BIOPSYBELL Srl, Cook Medical LLC, Danaher Corp., FUJIFILM Corp., General Electric Co., Hologic Inc., IZI Medical Products, Merit Medical Systems Inc., Metaltronica Spa, Planmed Oy, Scion Medical Technologies LLC, Siemens Healthineers AG, Suretech Medical Inc., Vector Medical, Zamar Care, and Carestream Health Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.